1. Introduction
===============

Cerebrovascular disease is a common and frequently-occurring disease that seriously endangers human health. It is one of the leading causes of death and disability worldwide, especially ischemic cerebrovascular disease, which is the most frequently prevalent \[[@b1-ijms-12-08208]\]. Increasing evidence suggests a critical role of oxidative stress in ischemic cerebrovascular disease \[[@b2-ijms-12-08208],[@b3-ijms-12-08208]\], and natural flavonoid antioxidants are well known as free radical scavengers \[[@b4-ijms-12-08208]\]. Scutellarin (4′,5,6-trihydroxyflavone-7-glucuronide), the major anti-oxidant constituent in breviscapine extracted from Chinese herb of *Erigeron breviscapus* (vant.) Hand.Mazz., showed the effectiveness on dilating blood vessels, improving microcirculation, increasing cerebral blood flow, and inhibiting platelet aggregation since the 1970s \[57\]. In addition, it has been clinically used to treat acute cerebral infarction and paralysis induced by cerebrovascular diseases such as hypertension, cerebral thrombosis, cerebral haemorrhage in China since 1984 \[[@b8-ijms-12-08208]\].

Although scutellarin has been clinically used for a long time, scutellarin has low water-solubility (just 0.16 mg/mL \[[@b9-ijms-12-08208]\]) and lipid-solubility (log P = −2.56 in PBS at pH 4.2 \[[@b10-ijms-12-08208]\]). Moreover, the bioavailability of scutellarin was very low; the absolute bioavailability in Beagle dog administered orally was rarely 0.4% \[[@b11-ijms-12-08208]\]. Furthermore, intravenous elimination half-life in dogs was as short as 52 min \[[@b12-ijms-12-08208]\]. Thus, various new formulations of scutellarin have been studied to overcome the above disadvantages, but its poor solubility, poor absorption and low bioavailability have not been completely solved until now. Interestingly, some researchers found that scutellarin was mainly absorbed in the form of its hydrolyzed product scutellarein by intestinal \[[@b13-ijms-12-08208]\], and scutellarein was much more easily absorbed with the triple bioavailability, after oral administration of scutellarin and scutellarein in equal amounts \[[@b14-ijms-12-08208]\]. Furthermore, in the clinical trials \[[@b15-ijms-12-08208]\], a large amount of scutellarein was found in urine and plasma after oral administration of breviscapine in subjects, indicating that breviscapine was firstly hydrolyzed into aglycone when reaching colon and was then absorbed as scutellarein as the real bioactive components in the body. Pharmacodynamics confirmed that scutellarein had better protective effect than scutellarin in rat cerebral ischemia \[[@b16-ijms-12-08208]\].

There is little scutellarein in *E. breviscapus* compared with large amount of scutellarin \[[@b16-ijms-12-08208]\]. Frakas \[[@b17-ijms-12-08208]\] and Cui \[[@b18-ijms-12-08208]\] had already completed the total synthesis of scutellarein, but the route was long and the yield was low. As a result, scutellarein cannot be purchased in the market like scutellarin, and it is also very difficult to obtain it through other methods. Thus, we tried the synthesis of scutellarein by hydrolyzing scutellarin in water according to a patent \[[@b19-ijms-12-08208]\]. Unfortunately, it was found that the reactants did not react. As a result, this study was intended to establish an efficient route to the synthesis of scutellarein by hydrolyzing scutellarin, and to preliminarily investigate its antioxidant activity in comparison with scutellarin, which will guide the search for more potent protective agents for ischemic cerebrovascular disease.

2. Materials and Methods
========================

2.1. Materials
--------------

Scutellarin was purchased from Mianning Jiexiang Co. Ltd. (Chengdu, China). 1,1-Diphenyl-2- picrylhydrazyl (DPPH), 2,2′-azinobis\[3-ethylbenzothiazoline-6-sulfonicacid\]-diammonium salt (ABTS) were purchased from Sigma Chemical Co. (Shanghai, China). Commercial kits used for determination of hydroxyl radical (^•^OH) scavenging activity was purchased from Jiancheng Institute of Biotechnology (Nanjing, China). Dulbecoo's Modified Eagles Medium (DMEM) was the product of Gibco. Heat-inactivated fetal calf serum was purchased from Sijiqing Institute of Biotechnology (Hangzhou, China). 3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Fluka. PC12 cell line was obtained from Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China).

2.2. General Procedure for the Synthesis of Scutellarein
--------------------------------------------------------

All the reagents were commercially available and used directly. Air- and moisture-sensitive liquids and solutions were transferred via syringe or stainless steel cannula. Organic solutions were concentrated by rotary evaporation below 45 °C at approximately 20 mm Hg. All non-aqueous reactions were carried out under anhydrous conditions using flame-dried glassware within an argon atmosphere in dry and freshly distilled solvents, unless otherwise noted. Reactions were monitored by thin-layer chromatography (TLC) carried out on 0.15\~0.20 mm Yantai silica gel plates (RSGF 254) using UV light as the visualizing agent. Chromatography was performed on Qingdao silica gel (160\~200 mesh) using petroleum ether (60\~90) and ethyl acetate as the eluting solvent.

Scutellarin (0.5 g) was added to 10 mL solution of H~2~SO~4~ in 0\~90% ethanol (0.5\~3 mol/L). Then the reaction mixture was refluxed at 90\~120 °C in N~2~ atmosphere for 6\~48 h. After cooling to 25 °C, the reaction mixture was added to ice water; the solid was filtered and then recrystallized with 90% ethanol to give the target compound scutellarein. The synthesis route of scutellarein was outlined in [Figure 1](#f1-ijms-12-08208){ref-type="fig"}. Detailed synthesis conditions were designed in [Table 1](#t1-ijms-12-08208){ref-type="table"}.

2.3. DPPH Radical-Scavenging Activity Assay
-------------------------------------------

The DPPH radical-scavenging activity assay was measured according to the method \[[@b20-ijms-12-08208]\] with a few modifications. 100 μL of the sample (4\~250 μmol/L, dissolved in ethanol) was added to 100 μL of ethanol solution containing DPPH radicals (80 μmol/L) in 96 well plates. The mixture was shaken and left for 30 min at room temperature in the dark, and the absorption was measured at 517 nm. Ascorbic acid was used as the positive control. A lower absorbance represents a higher DPPH scavenging activity. The percentage scavenging effect was calculated as scavenging rate (%) = \[1 − (*A*~1~ − *A*~2~)/*A*~0~\] × 100%, where *A*~0~ was the absorbance of the control (without sample), *A*~1~ was the absorbance in the presence of the sample and *A*~2~ was the absorbance without DPPH.

2.4. ABTS^+•^ Radical-Scavenging Activity Assay
-----------------------------------------------

The ABTS^+^*^•^* radical-scavenging activity assay was measured according to a literature procedure \[[@b21-ijms-12-08208]\]. ABTS (7 mmol/L) and K~2~S~2~O~8~ (2 mmol/L) were dissolved and mixed in deionized water, reacting for 12\~16 h at room temperature. The mixture (ABTS^+^*^•^* stock solution) was then diluted by phosphate buffer solution (PBS) to give an absorbance near 0.7 at 734 nm, defined as the reference absorbance (*A*~0~). *A*~0~ decreased to a stable value (*A*~1~) when 100 μL of ABTS^+^*^•^* was mixed with 100 μL the sample (1\~62.5 μmol/L) for 6 min. The percentage scavenging effect was calculated as scavenging rate (%) = \[1 − (*A*~1~ − *A*~2~)/*A*~0~\] × 100%, where *A*~0~ was the absorbance of the control (without sample), *A*~1~ was the absorbance in the presence of the sample and *A*~2~ was the absorbance without ABTS^+•^.

2.5. ^•^OH Radical-Scavenging Activity Assay
--------------------------------------------

The Hydroxyl radical-scavenging activity was measured according to the instruction of the assay kit (Nanjing Jiancheng Co., China). The percentage scavenging effect was calculated as scavenging rate (%) = \[1 − (*A*~1~ − *A*~2~)/*A*~0~\] × 100%, where *A*~0~ was the absorbance of the control (without sample), *A*~1~ was the absorbance in the presence of the sample and *A*~2~ was the absorbance without ^•^OH.

2.6. MTT Assay for PC12 Cell Survival
-------------------------------------

Protection against oxidative stress in PC12 cells was determined using the method \[[@b22-ijms-12-08208]\] with minor modifications. PC12 cells were cultured in DMEM supplemented with 10% (v/v) heat-inactivated fetal calf serum at 37 °C in a humidified atmosphere of 5% CO~2~. PC12 cells were grown on 96-well plates at a density of 5 × 10^4^ cells/mL (100 μL/well) for 24 h. The protective effect against oxidative stress were tested at different concentrations in three types of experiments: (a) coincubation of PC12 cells with sample and H~2~O~2~; (b) preincubation of cells for 30 min with sample before exposing them to H~2~O~2~; (c) preincubation of cells for 8 h with sample before exposing them to H~2~O~2~. After incubation for 3 h with H~2~O~2~ (400 μmol/L) at 37 °C in CO~2~ incubator, the cells were incubated with the 0.5 mg/mL MTT for 4 h. Then, all culture media were removed and 150 μL of DMSO was added to each well, vigorously shaking for 10 min. Finally, the absorbance was assessed at 517 nm. The inhibiting rate of H~2~O~2~-induced cytotoxicity in PC12 cells was calculated as inhibiting rate (%) = \[(*A*~1~ − *A*~2~)/(*A*~0~ − *A*~2~)\] × 100%, where *A*~1~ was the absorbance in the presence of sample and H~2~O~2~, *A*~2~ was the absorbance in the presence of H~2~O~2~ (model), *A*~0~ was the absorbance without sample and H~2~O~2~ (normal).

3. Results and Discussion
=========================

3.1. Optimization of Reaction Conditions for the Synthesis of Scutellarein
--------------------------------------------------------------------------

The optimization of reaction conditions were shown in [Table 1](#t1-ijms-12-08208){ref-type="table"}. The concentrated sulfuric acid was selected as a catalyst. Firstly, 0.5 g of scutellarin was added to 10 mL of 1 mol/L H~2~SO~4~ in water, and the reaction was taken at 90 °C for 6\~24 h in N~2~ atmosphere. However, there was no product; even the concentration of H~2~SO~4~ increased from 1 mol/L ([Table 1](#t1-ijms-12-08208){ref-type="table"}, run 1) to 3 mol/L ([Table 1](#t1-ijms-12-08208){ref-type="table"}, run 3), due to the poor water solubility of scutellarein. Then, the solvent of water was changed into ethanol, where scutellarein had good solubility. After several attempts, we found that increasing the concentration of ethanol ([Table 1](#t1-ijms-12-08208){ref-type="table"}, run 46) accelerated its hydrolysis and the yield increased to 2.1% in 90% ethanol ([Table 1](#t1-ijms-12-08208){ref-type="table"}, run 6). Subsequently, the concentration of H~2~SO~4~ was optimized, when the concentration of H~2~SO~4~ increased from 1.0 mol/L ([Table 1](#t1-ijms-12-08208){ref-type="table"}, run 7) to 3.0 mol/L ([Table 1](#t1-ijms-12-08208){ref-type="table"}, run 9), the yield of scutellarein was improved from 5.3% to 10.0%, and the yield could increase to 12.1% when the reaction time extended to 48 h ([Table 1](#t1-ijms-12-08208){ref-type="table"}, run 10). Lastly, the exogenous reaction temperature was studied in this reaction. When the reaction temperature was raised from 90 °C ([Table 1](#t1-ijms-12-08208){ref-type="table"}, Run 10) to 120 °C ([Table 1](#t1-ijms-12-08208){ref-type="table"}, Run 12), the yield of scutellarein increased from 12.1% to 17.3%. As a result, 3.0 mol/L H~2~SO~4~ in 90% ethanol and in N~2~ atmosphere at 120 °C for 48 h was implemented in the synthesis of scutellarein.

3.2. DPPH, ABTS^+•^, ^•^OH Radical-Scavenging Activity
------------------------------------------------------

DPPH, ABTS^+•^ (both stable radicals) and ^•^OH (generated by Fenton reaction), are widely used to evaluate the antioxidant capacity of complex mixtures and individual compounds \[[@b21-ijms-12-08208]\]. The *in vitro* antioxidant activity of scutellarein in comparison with scutellarin was evaluated by DPPH, ABTS^+•^, ^•^OH radical-scavenging activity assays. The IC~50~ value is defined as the concentration of sample that causes 50% loss of the radical. As illustrated in [Figure 2](#f2-ijms-12-08208){ref-type="fig"} and [Table 2](#t2-ijms-12-08208){ref-type="table"}, scutellarein (IC~50~ 16.84 μmol/L for DPPH, 3.00 μmol/L for ABTS^+•^, 0.31 mmol/L for ^•^OH) had stronger radical-scavenging capacities than scutellarin (IC~50~ 17.56 μmol/L for DPPH, 3.53 μmol/L for ABTS^+•^, 3.19 mmol/L for ^•^OH), which indicated that scutellarein is an effective natural antioxidant that might be a promising candidate for ischemic cerebrovascular disease.

3.3. Protective Effect on H~2~O~2~-Induced Cytotoxicity in PC12 Cells
---------------------------------------------------------------------

PC12 cells can adopt a neuronal phenotype and have been used extensively as a model for catecholamine-secreting neuronal cells \[[@b23-ijms-12-08208]\]. Active mitochondria of living cells can cleave MTT to produce formazan, the amount of which is directly related to the number of living cells. As shown in [Table 3](#t3-ijms-12-08208){ref-type="table"}, cell viability markedly decreased after PC12 cells were exposed to H~2~O~2~. However, when the cells were incubated with scutellarein or scutellarin, H~2~O~2~-induced cell toxicity was significantly attenuated, and the protective effect of scutellarein was dose-dependent. However, coincubation of cells showed better protective effect than preincubation for some time against H~2~O~2~ cytotoxicity, and the protective effect decreased as preincubation time was prolonged, which may be due to the unstability of scutellarein. Therefore, coincubation was considered to more effectively evaluate cytoprotection of scutellarein; and scutellarein showed a significantly better protective effect than scutellarin. The cellular protective effect of scutellarein might be resulted from its antioxidant action mainly including preventing lipid peroxidation by eliminating radicals \[[@b24-ijms-12-08208],[@b25-ijms-12-08208]\].

4. Conclusion
=============

In summary, an efficient route was reported for the synthesis of scutellarein by hydrolyzing scutellarin. Essential to the synthesis was the implementation of H~2~SO~4~ in 90% ethanol in N~2~ atmosphere. The *in vitro* antioxidant assays clearly demonstrated that scutellarein had stronger scavenging capacities toward DPPH, ABTS^+•^, ^•^OH free radicals than scutellarin, and had better protective effect on H~2~O~2~-induced cytotoxicity in PC12 cells. The results suggested that it would be a promising potent agent for the therapy of ischemic cerebrovascular disease. In addition, these findings concluded the need for further study on the pharmacokinetics and its bioactivities other than antioxidant activities.

This work was supported by National Natural Science Foundation of China (No. 30873235, 81001382), the Program for New Century Excellent Talents by the Ministry of Education (NCET**-**09-0163), Research Fund for the Doctoral Program of Higher Education of China (20093237120012), 2009' Program for Excellent Scientific and Technological Innovation Team of Jiangsu Higher Education, National Key Technology R&D Program (2008BAI51B01), and Main Training Fund of Nanjing University of Chinese Medicine (10XPY02). This research was also financially supported by A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (ysxk-2010), and Construction Project for Jiangsu Engineering Center of Innovative Drug from Blood-conditioning TCM Formulae.

![Synthesis of scutellarein.](ijms-12-08208f1){#f1-ijms-12-08208}

![(**A**) The 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity assay; (**B**) 2,2′-azinobis\[3-ethylbenzothiazoline-6-sulfonicacid\]- diammonium salt (ABTS^+•^) radical-scavenging activity assay; (**C**) hydroxyl radical (^•^OH) radical-scavenging activity assay.](ijms-12-08208f2){#f2-ijms-12-08208}

###### 

Optimization of reaction conditions in the synthesis of scutellarein by hydrolyzing scutellarin.

  Run      Reaction conditions                                  Yield (%)
  -------- ---------------------------------------------------- ------------
  **1**    1.0 mol/L H~2~SO~4~ in water, 90 °C, 6\~24 h         No product
  **2**    2.0 mol/L H~2~SO~4~ in water, 90 °C, 6\~24 h         No product
  **3**    3.0 mol/L H~2~SO~4~ in water, 90 °C, 6\~24 h         No product
  **4**    0.5 mol/L H~2~SO~4~ in 70% ethanol, 90 °C, 6\~24 h   No product
  **5**    0.5 mol/L H~2~SO~4~ in 80% ethanol, 90 °C, 6\~24 h   No product
  **6**    0.5 mol/L H~2~SO~4~ in 90% ethanol, 90 °C, 24 h      2.1
  **7**    1.0 mol/L H~2~SO~4~ in 90% ethanol, 90 °C, 24 h      5.3
  **8**    2.0 mol/L H~2~SO~4~ in 90% ethanol, 90 °C, 24 h      8.5
  **9**    3.0 mol/L H~2~SO~4~ in 90% ethanol, 90 °C, 24 h      10.0
  **10**   3.0 mol/L H~2~SO~4~ in 90% ethanol, 90 °C, 48 h      12.1
  **11**   3.0 mol/L H~2~SO~4~ in 90% ethanol, 100 °C, 48 h     15.2
  **12**   3.0 mol/L H~2~SO~4~ in 90% ethanol, 120 °C, 48 h     17.3

###### 

*In vitro* antioxidant activity of scutellarein in comparison with scutellarin in DPPH assay (IC~50~ in μmol/L), ABTS^+•^ assay (IC~50~ in μmol/L), ^•^OH assay (IC~50~ in mmol/L).

  Compounds      IC~50~           
  -------------- -------- ------- ------
  Scutellarein   16.84    3.00    0.31
  Scutellarin    17.56    3.53    3.19
  Vitamin C      24.81    12.56   1.12

###### 

Attenuation of H~2~O~2~-induced PC12 cell damage by scutellarein (*x ± s*, *n* = 5).

  Drug (μmol/L)      Coincubation                                                     Preincubation for 30 min   Preincubation for 8 h                                                                                                                      
  ------------------ ---------------------------------------------------------------- -------------------------- ----------------------------------------------------------------- ------- ---------------------------------------------------------------- -------
  Normal             0.550 ± 0.004                                                    ---                        0.589 ± 0.003                                                     ---     0.624 ± 0.004                                                    ---
  H~2~O~2~           0.353 ± 0.006 [\#\#](#tfn3-ijms-12-08208){ref-type="table-fn"}   ---                        0.319 ± 0.0123 [\#\#](#tfn3-ijms-12-08208){ref-type="table-fn"}   ---     0.375 ± 0.015 [\#\#](#tfn3-ijms-12-08208){ref-type="table-fn"}   ---
  Scutellarin/100    0.433 ± 0.009 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}   40.78                      0.440 ± 0.009 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}    44.81   0.482 ± 0.002 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}   42.97
  Scutellarein/100   0.540 ± 0.038 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}   94.92                      0.500 ± 0.040 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}    67.04   0.458 ± 0.013 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}   33.33
  Scutellarein/10    0.422 ± 0.007 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}   35.32                      0.395 ± 0.019 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}    28.12   0.414 ± 0.002 [\*\*](#tfn1-ijms-12-08208){ref-type="table-fn"}   15.96
  Scutellarein/1     0.362 ± 0.002                                                    4.57                       0.336 ± 0.007 [\*](#tfn2-ijms-12-08208){ref-type="table-fn"}      6.10    0.383 ± 0.010                                                    ---

*p* \< 0.01,

*p* \< 0.05 *vs*. H~2~O~2~ group;

*p* \< 0.01 *vs*. Normal group.
